| ||
| Lilly drug helps keep lung cancer at bay -study Reuters The 939-patient study, presented at the annual meeting of the American Society of Clinical Oncology in Chicago on Sunday, included subjects with the nonsquamous form of non-small cell lung cancer -- the most common type of lung cancer which affects an ... See all stories on this topic » | ||
| Study: Pfizer lung cancer pill may double survival The Associated Press The experimental drug works by turning off that enzyme, with a rapid and dramatic effect that's long-lasting, said Shaw, a thoracic oncologist at Massachusetts General Hospital Cancer Center. "This is not a cure for this type of patients. ... See all stories on this topic » | ||
| Agennix Announces New Data From Talactoferrin Phase II Trials in Non-Small ... Gamut News Data from the Company's Phase II trial evaluating talactoferrin plus best supportive care compared to placebo plus best supportive care in 2nd-line+ non-small cell lung cancer (NSCLC) were presented as a poster, "The effect of talactoferrin on overall ... See all stories on this topic » | ||
| Taking Chemo Drug Continuously Delayed Lung Cancer's Return U.S. News & World Report By Amanda Gardner SUNDAY, June 5 (HealthDay News) -- While most patients with advanced lung cancer only take four courses of two chemotherapy drugs and then stop until recurrence occurs, continuing treatment with one of those drugs may delay return of ... See all stories on this topic » | ||
| Exelixis' Cabozantinib Demonstrates Broad Clinical Activity in Multiple Tumor ... Business Wire (press release) Lower rates of disease control at week 12 were observed in small cell lung cancer (SCLC; 38%), pancreatic adenocarcinoma (35%) and gastric/GEJ cancer (33%), and these tumor cohorts will not be studied further in the RDT. ... See all stories on this topic » | ||
| Crizotinib Continues to Produce High Response in ALK+ NSCLC Internal Medicine News Digital Network CHICAGO – Nearly two-thirds of patients with non–small cell lung cancer who were positive for the anaplastic lymphoma kinase responded to the experimental agent crizotinib. The responses were "rapid, dramatic, and durable," investigators reported at ... See all stories on this topic » | ||
| City of Hope researchers to present rectal cancer, palliative care ... EurekAlert (press release) "Patients who receive additional chemotherapy before their surgical procedures may achieve a greater rate of pathologic complete response without increases in side effects or complications compared to the standard approach, which can lead to better ... See all stories on this topic » | ||
| ||
| Health officials urge county to enact ban Muncie Star Press According to the Journal of the American Medical Association, food service workers are 50 percent more likely than the general population to develop lung cancer, largely because many of them are exposed to secondhand smoke on the job. ... See all stories on this topic » | ||
| Healthy Memphis: Men can make big difference in their own well-being Memphis Commercial Appeal Too many men in Tennessee die from heart disease, cancer (especially lung and head and neck), liver disease, and accidents (motor vehicle, suicides and homicides.) Heart disease is a major cause of death for Tennessee men. Accidents are the No. ... See all stories on this topic » | ||
| ||
| Smokefree workplace legislation approved by California Senate San Francisco Chronicle (blog) This bill helps assure a healthy workplace for all Californians." This bill is co-sponsored by the American Cancer Society, the American Lung Association and the American Heart Association. It will next be sent to the State Assembly for consideration. See all stories on this topic » | ||
| ||
| New Study Released Today Showed Patients With Deadly Form of Lung Cancer Lived ... SYS-CON Media (press release) What are the possible side effects of ALIMTA? Most patients taking ALIMTA will have side effects. Sometimes it is not always possible to tell whether ALIMTA, another medicine, or the cancer itself is causing these side effects. ... See all stories on this topic » | ||
| Eli Lilly Chemo Drug Delays Some Lung Cancer Progression Capital.gr (press release) The drug is already approved by the FDA for newly diagnosed patients with advanced nonsquamous non-small cell lung cancer to be used with another chemotherapy, and to maintain the effect of initial treatment with chemotherapy. ... See all stories on this topic » | ||
| Hormone-blocking drug reduces breast cancer risk CBS News Lung inflammation and lymphedema — painful arm swelling caused by poor drainage — were more common with wider radiation, but doctors said these side effects were worth the benefit of fewer cancer recurrences. The results are "potentially ... See all stories on this topic » | ||
| Stop smoking Manila Bulletin Please consult a doctor – a family medicine practitioner, a psychiatrist, a lung specialist, or an ENT specialist for guidance about nicotine substitutes. They may come in the form of gum, patches, inhalers, or lozenges. 5. Ask about drugs for quitting ... See all stories on this topic » |
| ||
| Study: Pfizer lung cancer pill may double survival « New Hampshire ... By Associated Press Similarly, in a midstage study of 136 patients who failed at least one previous cancer treatment, 54 percent had their tumors shrink by about a third or more and 83 percent had tumors shrink somewhat. Most patients had mild side effects ... New Hampshire Journal - http://nhjournal.com/ | ||
| Study: Pfizer lung cancer pill may double survival - Health - The ... A much-anticipated drug for advanced lung cancer from Pfizer Inc. appears to double survival over standard drugs against tumors with a certain genetic mutation, according to research presented Sunday. ... Pfizer Inc.'s Aromasin cut the risk of developing breast cancer by more than half, without the side effects that have curbed enthusiasm for other prevention drugs, a major study found. ... The Olympian Online -- - NEWS UPDATES - http://www.theolympian.com/breakingnews/ | ||
| Taking Chemo Drug Continuously Delayed Lung Cancer's Return ... While most patients with advanced lung cancer only take four courses of two chemotherapy drugs and then stop until recurrence occurs, continuing treatment with. ... Side effects were about the same as those seen in previous trials of Alimta, with the only significant increases in problems being fatigue, anemia and low white blood cell count. But in all those cases, the incidence was lower than ... Drugs.com - Daily MedNews - http://www.drugs.com/medical-news.html |
| ||
| Lung cancer treatment side effects Lung Cancer Side Effects. The side effects of lung cancer treatment depend on the type of treatment and may be different for each person. The side effects ... www.usgovernmentbenefits.org/hd/index.php?t=lung... | ||
| Lung Cancer: medical food with good treatment effect | Disease ... Basic methods of treatment are divided into surgical treatment for lung cancer, radiotherapy, chemotherapy and traditional Chinese medicine for treatment. ... www.nik2.com/31.html |
Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment